If you need more lookups,
subscriptions start at $34 USD/month.
Paul Docherty Location
Cambridge, GB
Paul Docherty Work
Head of Sales @ (November 2024 - Present)
UK and Nordics Business Manager @ (September 2023 - November 2024)
Director Of Business Development @ (October 2020 - July 2023)
Co-Founder @ (November 2019 - November 2020)
Co-Founder and Commercial Director @ Ex5 Genomics (May 2019 - July 2023)
Sales, BD, Relationship and Alliance Manager @ Hologic (Formerly Gen-Probe, Tepnel) (January 2012 - May 2019)
Business Development Manager @ Gentronix Ltd (January 2008 - December 2011)
Sales Manager @ Novexin Ltd (January 2005 - December 2008)
European Account Manager and Scandinavian Business Manager @ BioVeris and IGEN (January 2001 - December 2005)
Paul Docherty Education
National Institutes of Health, MD, USA
Post-Doctorate
1998-2000
University of Aberdeen / Imperial College, London
Doctor of Philosophy (PhD)
1994-1998
University of Salford, UK / University of Toledo, USA
BSc (Hons) 2:1
1991-1994
Paul Docherty Skills
Water
Microsoft Excel
Management
Companion Diagnostics
Contract Research
CRO
Clinical Development
Molecular Biology
Sales Management
Biochemistry
Molecular Diagnostics
PCR
Customer Service
Biotechnology
Pharmaceuticals
JavaScript
Precision Medicine
qPCR
Strategic Planning
Instrumentation
Marketing
Account Management
Life Sciences
Biomarkers
Key Account Development
Drug Development
Diagnostics
Genomics
ELISA
Business Development
Tobacco
Sales
Personalized Medicine
Paul Docherty Summary
Paul Docherty, based in Cambridge, GB, is currently a Head of Sales at ProtonDx. Paul Docherty brings experience from previous roles at SeqOne Genomics, Yourgene Health, The Genome Store and Ex5 Genomics. Paul Docherty holds a 1998 - 2000 Post-Doctorate @ National Institutes of Health, MD, USA. With a robust skill set that includes Water, Microsoft Excel, Management, Companion Diagnostics, Contract Research and more. Paul Docherty has 1 emails on RocketReach.
Looking for a different Paul Docherty?
Find contact details for 700 million professionals.